Comparison of three molecular methods to detect mutations in KRAS, NRAS, BRAF and PIK3CA in metastatic colorectal cancer (mCRC).

被引：0
|
作者：
Santos, Cristina
Garcia-Carbonero, Rocio
Alfonso, Pilar Garcia
Azuara, Daniel
Varela, Mar
Navarro-Perez, Valentin
Carrato, Alfredo
Elez, Elena
Gomez-Espana, M. Auxiliadora
Losa, Ferran
Montagut, Clara
Massuti, Bartomeu
Manzano, Jose Luis
Vieitez, Jose M.
Valladares, Manuel
Sanjuan, Xavier
Capella, Gabriel
Aranda, Enrique
Tabernero, Josep
Salazar, Ramon
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.3559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3559
引用
收藏
页数：2
相关论文
共 50 条
  • [31] EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
    Bujko, Mateusz
    Kober, Paulina
    Tysarowski, Andrzej
    Matyja, Ewa
    Mandat, Tomasz
    Bonicki, Wieslaw
    Siedlecki, Janusz Aleksander
    [J]. ONCOLOGY LETTERS, 2014, 7 (06) : 2019 - 2022
  • [32] Scanning for KRAS, NRAS, BRAF, and PIK3CA Mutations by DNA Melting Analysis with TaqMan Probes
    Botezatu, I. V.
    Panchuk, I. O.
    Stroganova, A. M.
    Senderovich, A. I.
    Kondratova, V. N.
    Shelepov, V. P.
    Lichtenstein, A. V.
    [J]. MOLECULAR BIOLOGY, 2017, 51 (01) : 41 - 48
  • [33] Scanning for KRAS, NRAS, BRAF, and PIK3CA mutations by DNA melting analysis with TaqMan probes
    I. V. Botezatu
    I. O. Panchuk
    A. M. Stroganova
    A. I. Senderovich
    V. N. Kondratova
    V. P. Shelepov
    A. V. Lichtenstein
    [J]. Molecular Biology, 2017, 51 : 41 - 48
  • [34] Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer
    Lu, Weipeng
    Wei, Hong
    Li, Mei
    Wang, Hai
    Liu, Lina
    Zhang, Qiuping
    Liu, Lisha
    Lu, Shen
    [J]. MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 1219 - 1224
  • [35] The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
    V Eklöf
    M L Wikberg
    S Edin
    A M Dahlin
    B-A Jonsson
    Å Öberg
    J Rutegård
    R Palmqvist
    [J]. British Journal of Cancer, 2013, 108 : 2153 - 2163
  • [36] KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer
    Mao, Chen
    Zhou, Junhua
    Yang, Zuyao
    Huang, Yafang
    Wu, Xinyin
    Shen, Hong
    Tang, Jinling
    Chen, Qing
    [J]. PLOS ONE, 2012, 7 (05):
  • [37] Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
    Grazia Palomba
    Valentina Doneddu
    Antonio Cossu
    Panagiotis Paliogiannis
    Antonella Manca
    Milena Casula
    Maria Colombino
    Annamaria Lanzillo
    Efisio Defraia
    Antonio Pazzola
    Giovanni Sanna
    Carlo Putzu
    Salvatore Ortu
    Mario Scartozzi
    Maria Teresa Ionta
    Giovanni Baldino
    Giuseppina Sarobba
    Francesca Capelli
    Tito Sedda
    Luciano Virdis
    Michela Barca
    Giulia Gramignano
    Mario Budroni
    Francesco Tanda
    Giuseppe Palmieri
    [J]. Journal of Translational Medicine, 14
  • [38] The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
    Eklof, V.
    Wikberg, M. L.
    Edin, S.
    Dahlin, A. M.
    Jonsson, B-A
    Oberg, A.
    Rutegard, J.
    Palmqvist, R.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 2153 - 2163
  • [39] Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
    Palomba, Grazia
    Doneddu, Valentina
    Cossu, Antonio
    Paliogiannis, Panagiotis
    Manca, Antonella
    Casula, Milena
    Colombino, Maria
    Lanzillo, Annamaria
    Defraia, Efisio
    Pazzola, Antonio
    Sanna, Giovanni
    Putzu, Carlo
    Ortu, Salvatore
    Scartozzi, Mario
    Ionta, Maria Teresa
    Baldino, Giovanni
    Sarobba, Giuseppina
    Capelli, Francesca
    Sedda, Tito
    Virdis, Luciano
    Barca, Michela
    Gramignano, Giulia
    Budroni, Mario
    Tanda, Francesco
    Palmieri, Giuseppe
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [40] Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
    De Roock, Wendy
    Claes, Bart
    Bernasconi, David
    De Schutter, Jef
    Biesmans, Bart
    Fountzilas, George
    Kalogeras, Konstantine T.
    Kotoula, Vassiliki
    Papamichael, Demetris
    Laurent-Puig, Pierre
    Penault-Llorca, Frederique
    Rougier, Philippe
    Vincenzi, Bruno
    Santini, Daniele
    Tonini, Giuseppe
    Cappuzzo, Federico
    Frattini, Milo
    Molinari, Francesca
    Saletti, Piercarlo
    De Dosso, Sara
    Martini, Miriam
    Bardelli, Alberto
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    Tabernero, Josep
    Macarulla, Teresa
    Di Fiore, Frederic
    Gangloff, Alice Oden
    Ciardiello, Fortunato
    Pfeiffer, Per
    Qvortrup, Camilla
    Hansen, Tine Plato
    Van Cutsem, Eric
    Piessevaux, Hubert
    Lambrechts, Diether
    Delorenzi, Mauro
    Tejpar, Sabine
    [J]. LANCET ONCOLOGY, 2010, 11 (08): : 753 - 762
12345